Viromune is an Ayurvedic formulation consisting of 17 potent herbs and their properties vary from antiviral to pure immunity boosting, together with a properly balanced mix of important nutritional vitamins and minerals, Kunnath Pharmaceuticals mentioned.
The intention is to promote 25 lakh packets of the product within the first yr, 50 lakh packets within the second yr and 1 crore within the third yr throughout the nation, Kunnath Pharmaceuticals MD Ok C Abraham advised.
“We are planning to achieve the Rs 2,000 crore turnover target in the coming three years. Our new product line will help us in this process,” he added.
The firm is spending over Rs 100 crore in analysis and improvement and on the brand new merchandise, Kunnath Pharmaceuticals in a press release.
“We are already exporting our products to 12 countries, which include Australia, Canada, the UAE etc. (The) company is envisaging a plan to reach at least 75 countries in the near future,” Abraham mentioned.